Merck’s COVID-19 Pill Is Ivermectin All Over Again

This article is dedicated to Jack Posobiec, who tweeted:

What if instead of a vaccine we just were able to get exposed to a weak version of the virus that enabled us to build the antibodies we need to fight the real thing

Although obviously comical, Posobiec’s tweet shows something about many Trump supporters, and those on the right-wing of politics more generally: They’re willing to do anything that might help COVID-19 — except take vaccines. Some, such as Daniel Horowitz, are still doubling down on Ivermectin — although those types are becoming rarer and rarer. What is much more common is people jumping from potential COVID-19 cure to potential COVID-19 cure, trying to find something — again, besides vaccines — that will help them.

Back in September, that new COVID-19 cure was Iodine — specifically, gargling Iodine. Enter the pharmaceutical company Merck & Co. along with the partner company Ridgeback Biotherapeutics, which now claim to have created an oral antibiotic to treat COVID-19.

Here’s what The Wall Street Journal wrote on the pill on 10/1/2021:

The drug, called molnupiravir, was performing so well in its late-stage trial that Merck and Ridgeback said they stopped enrolling subjects after discussions with the U.S. Food and Drug Administration.